Evaluation of genetic and phenotypic consistency of Bacillus coagulans MTCC 5856: a commercial probiotic strain

World Journal of Microbiology and Biotechnology

Volumn 32, Issue 4, 2016, Pages 1-12

  Majeed, Muhammed ^a,b   Nagabhushanam, Kalyanam ^b   Natarajan, Sankaran ^a   Sivakumar, Arumugam ^a   Eshuis de Ruiter, Talitha ^c   Booij Veurink, Janine ^c   de Vries, Ynte P ^c   Ali, Furqan ^a  

^a Sami Labs Limited   (India)

^b SABINSA CORPORATION   (United States)

^c FRIESLANDCAMPINA   (Netherlands)

Author keywords

16S rRNA; Bacillus coagulans MTCC 5856; Genotypic fingerprinting; LactoSpore ; MLST

Indexed keywords

ACID RESISTANCE; RNA; TEMPERATURE;

16S RRNA; ANTI-MICROBIAL ACTIVITY; BACILLUS COAGULANS; BOX-PCR FINGERPRINTING; COMMERCIAL PRODUCTIONS; GENOTYPIC FINGERPRINTING; MLST; TEMPERATURE CONDITIONS;

BACTERIOLOGY;

BACTERIAL DNA; BACTERIAL PROTEIN; PROBIOTIC AGENT; RIBOSOME DNA; RNA 16S;

BACILLUS; BACTERIUM IDENTIFICATION; CLASSIFICATION; DNA FINGERPRINTING; GENETICS; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PHYSIOLOGY; PROCEDURES;

BACILLUS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; DNA FINGERPRINTING; DNA, BACTERIAL; DNA, RIBOSOMAL; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PROBIOTICS; RNA, RIBOSOMAL, 16S;

EID: 84959376542     PISSN: 09593993     EISSN: 15730972     Source Type: Journal    
DOI: 10.1007/s11274-016-2027-2     Document Type: Article

References (39)

1. Ames BN, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/Mammalian-Microsome mutagenicity test. Mutat Res 31:347–364
2. Anonymous (2002) Lactobacillus sporogenes. Altern Med Rev 7:340–342
3. Aureli P, Fiore A, Scalfaro C, Casale M, Franciosa G (2010) National survey outcomes on commercial probiotic food supplements in Italy. Int J Food Microbiol 137:265–273
4. Canganella F, Paganini S, Ovidi M, Vettraino AM, Bevilacqua L, Massa S, Trovatelli LD (1997) A microbiological investigation on probiotic pharmaceutical products used for human health. Microbiol Res 152:171–179
5. Cintas LM, Rodriguez JM, Fernandez MF, Sletten K, Nes IF, Hernandez PE, Holo H (1995) Isolation and characterization of pediocin L50, a new bacteriocin from Pediococcus acidilactici with a broad inhibitory spectrum. Appl Environ Microbiol 61:2643–2648
6. CLSI (2012) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 9th ed. M07-A9. Clinical and Laboratory Standards Institute, Wayne
7. Coronado BE, Opal SM, Yoburn DC (1995) Antibiotic-induced d-lactic acidosis. Ann Intern Med 122:839–842
8. De Clerck E, Rodriguez-Diaz M, Forsyth G, Lebbe L, Logan NA, DeVos P (2004) Polyphasic characterization of Bacillus coagulans strains, illustrating heterogeneity within this species, and emended description of the species. Syst Appl Microbiol 27:50–60
9. EFSA (2012) European Food Safety Authority. Scientific opinion on guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J 10:2740
10. FAO/WHO (2002) Report of a joint FAO/WHO expert consultation on guidelines for the evaluation of probiotics in food. World Health Organization and Food and Agriculture Organization of the United Nations, London
11. From C, Pukall R, Schumann R, Hormazábal V, Granum E (2005) Toxin-producing ability among Bacillus spp. outside the Bacillus cereus group. Appl Environ Microbiol 71:1178–1183
12. Gill H, Prasad J (2008) Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol 606:423–454
13. Gilliland SE, Staley TE, Bush LJ (1984) Importance of bile tolerance of Lactobacillus acidophilus used as a dietary adjunct. J Dairy Sci 67:3045–3051
14. Hamilton-Miller JMT, Shah S (2002) Deficiencies in microbiological quality and labelling of probiotic supplements. Int J Food Microbiol 72:175–176
15. Heyrman J, Swings J (2001) 16S rDNA sequence analysis of bacterial isolates from biodeteriorated murals paintings in the Servilia tomb (necropolis of Carmona, Seville, Spain). Syst Appl Microbiol 24:417–422
16. Hoffmaster AR, Novak RT, Marston CK, Gee JE, Helsel L, Pruckler JM, Wilkins PP (2008) Genetic diversity of clinical isolates of Bacillus cereus using multilocus sequence typing. BMC Microbiol 8:191
17. Hughes VL, Hillier SL (1990) Microbiologic characteristics of Lactobacillus products used for colonization of the vagina. Obstet Gynecol 75:244–248
18. Hyronimus B, Marrec CL, Hadj SA, Deschamps A (2000) Acid and bile tolerance of spore-forming lactic acid bacteria. Int J Food Microbiol 61:193–197
19. ICH (2003) International conference on harmonisation. The European agency for the evaluation of medicinal products. ICH Q1A (R2) Stability testing guidelines: stability testing of new drug substances and products (CPMP/ICH/2736/99). ICH, Geneva
20. Jurenka JS (2012) Bacillus coagulans: monograph. Altern Med Rev 7:76–81
21. Kahya E, Bayraktar E, Mehmetoglu U (2001) Optimization of process parameters for reactive lactic acid extraction. Turk J Chem 25:223–230
22. Kämpfer P, Steiof M, Dott W (1991) Microbiological characterization of a fuel-oil contaminated site including numerical identification of heterotrophic water and soil bacteria. Microb Ecol 21:227–251
23. Louws FJ, Fulbright DW, Stephens CT, De Bruijn FJ (1994) Specific genomic fingerprints of phytopathogenic Xanthomonas and Pseudomonas Pathovars and strains generated with repetitive sequences and PCR. Appl Environ Microbiol 60:2286–2295
24. ®: the effective probiotics. NutriScience Publishers, Inc., Piscataway
25. Majeed M, Majeed S, Nagabhushanam K, Natarajan S, Sivakumar A, Ali F (2016) Evaluation of the stability of Bacillus coagulans MTCC 5856 during processing and storage of functional foods. Int J Food Sci Tech. doi:10.1111/ijfs.13044
26. Marmur J (1961) Procedure for the isolation of deoxyribonucleic acid from microorganisms. J Mol Biol 3:208–218
27. Maron DM, Ames BN (1983) Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215
28. Marteau P (2001) Safety aspects of probiotic products. Scand J Nutr 45:22–24
29. Munakata S, Arakawa C, Kohira R, Fujita Y, Fuchigami T, Mugishima H (2010) A case of d-lactic acid encephalopathy associated with use of probiotics. Brain Dev 32:691–694
30. OECD (1997) Test guidelines 471. Bacterial reverse mutation test. In: OECD guidelines for testing of chemicals. Organization for Economic Cooperation and Development, Paris
31. Olive DM, Bean P (1999) Principles and applications of methods for DNA-based typing of microbial organisms. J Clin Microbiol 37:1661–1669
32. Patel MA, Ou MS, Harbrucker R, Aldrich HC, Buszko ML, Ingram LO, Shanmugan KT (2006) Isolation and characterization of acid-tolerant, thermophilic bacteria for effective fermentation of biomass-derived sugars to lactic acid. Appl Environ Microbiol 72:3228–3235
33. Priest FG, Barker M, Baillie LW, Holmes EC, Maiden MC (2004) Population structure and evolution of the Bacillus cereus group. J Bacteriol 186:7959–7970
34. Sanders ME, Klaenhammer TR, Ouwehand AC, Pot B, Johansen E, Heimbach JT, Marco ML, Tennilä J, Ross RP, Franz C, Pagé N, Pridmore RD, Leyer G, Salminen S, Charbonneau D, Call E, Lenoir-Wijnkoop I (2014) Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Ann N Y Acad Sci 1309:1–18
35. Shida K, Nomoto K (2013) Probiotics as efficient immunopotentiators: translational role in cancer prevention. Indian J Med Res 138:808–814
36. Versalovic J, Schneider M, de Bruijn FJ, Lupski JR (1994) Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reaction. Methods Mol Cell Biol 5:25–40
37. Weese JS (2002) Microbiologic evaluation of commercial probiotics. J Am Vet Med Assoc 220:794–797
38. Weese JS, Martin H (2011) Assessment of commercial probiotic bacterial contents and label accuracy. Can Vet J 52:43–46
39. Zhu LJ, Zheng FY, Zhao YZ, Xing XN, Li Q, Gu GX (2006) Study on application of rep-PCR fingerprint in rapid identification of beer-spoilager. Chin J Biotechnol 22:1013–1020